Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests are comparatively easy to perform and can be performed with minimum amount of training. Infectious diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017, wherein point of care diagnostics could be helpful.
Market Dynamics
Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer’s supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth.
Key features of the study:
- This report provides in-depth analysis of point of care infectious disease diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global point of care infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global point of care infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care infectious disease diagnostics market
Detailed Segmentation:
- Global Point of Care Infectious Disease Diagnostics Market, By Technology:
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- Global Point of Care Infectious Disease Diagnostics Market, By Application:
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections (HAIs)
- Sexual Health Disorders
- Others
- Global Point of Care Infectious Disease Diagnostics Market, By End User:
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- Global Point of Care Infectious Disease Diagnostics Market, By Geography:
- North America
- By Technology:
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- By Application:
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections (HAIs)
- Sexual Health Disorders
- Others
- By End User:
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- By Country:
- Europe
- By Technology:
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- By Application:
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections (HAIs)
- Sexual Health Disorders
- Others
- By End User:
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Technology:
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- By Application:
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections (HAIs)
- Sexual Health Disorders
- Others
- By End User:
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Technology:
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- By Application:
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections (HAIs)
- Sexual Health Disorders
- Others
- By End User:
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- By Country:
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- By Technology:
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- By Application:
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections (HAIs)
- Sexual Health Disorders
- Others
- By End User:
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Technology:
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- By Application:
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections (HAIs)
- Sexual Health Disorders
- Others
- By End User:
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- By Country:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Danaher Corporation*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Abbott Laboratories
- Acon Laboratories, Inc.
- Hoffman-La Roche Ltd.
- Becton, Dickinson, and Company
- Trinity Biotech Plc
- AccuBioTech Co., Ltd.
- Cardinal Health, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
